Latest News & Features
Refine Search
Americas
The US Court of Appeals for the Federal Circuit has again found a patent covering a heart rate monitor to be valid, reversing and remanding a district court’s decision for further consideration in the long-running Biosig v Nautilus case. 28 April 2015
Americas
Hedge fund manager Kyle Bass and his Coalition for Affordable Drugs is continuing its campaign against certain pharmaceutical patents, most recently seeking to invalidate patents owned by Celgene and NPS Pharma. 27 April 2015
Americas
Japanese pharmaceutical company Hisamitsu and its US-based subsidiary Noven have sued Mylan for allegedly infringing two patents covering oestrogen patch Minivelle. 27 April 2015
Americas
Drug maker Shire, alongside two other companies, has sued Amneal Pharmaceuticals for allegedly infringing a patent related to Lialda, a drug for treating ulcerative colitis. 24 April 2015
Biotechnology
Biotechnology companies are concerned about the Dutch government’s plans to allow small plant breeders to develop new breeds while avoiding paying licensing fees, according to reports. 23 April 2015
Asia
Pharmaceutical company Teva has offered to buy fellow drug maker Mylan in a deal that could be worth $40 billion. 22 April 2015
Americas
The Supreme Court of Canada has dismissed an appeal by French pharmaceutical company Sanofi in its patent dispute with Canadian generic drug maker Apotex. 22 April 2015
Americas
Texas hedge fund manager Kyle Bass has sought another inter partes review, this time to challenge a patent covering Pharmacyclics’ cancer drug Imbruvica. 22 April 2015
Americas
Healthcare company Fresenius Kabi and India-based generic drug maker Claris Lifesciences have settled their patent dispute, ending pending litigation. 21 April 2015
Big Pharma
Law firm Taylor Wessing has promoted senior associates Matt Royle and Ed Vickers to partner and senior counsel, respectively. 21 April 2015